179 related articles for article (PubMed ID: 33588604)
21. Diminished expression of major histocompatibility complex facilitates the use of human induced pluripotent stem cells in monkey.
Wang X; Lu M; Tian X; Ren Y; Li Y; Xiang M; Chen S
Stem Cell Res Ther; 2020 Aug; 11(1):334. PubMed ID: 32746912
[TBL] [Abstract][Full Text] [Related]
22. Immunogenicity of induced pluripotent stem cells.
Zhao T; Zhang ZN; Rong Z; Xu Y
Nature; 2011 May; 474(7350):212-5. PubMed ID: 21572395
[TBL] [Abstract][Full Text] [Related]
23. Immune potential of allogeneic equine induced pluripotent stem cells.
Aguiar C; Theoret C; Smith O; Segura M; Lemire P; Smith LC
Equine Vet J; 2015 Nov; 47(6):708-14. PubMed ID: 25196173
[TBL] [Abstract][Full Text] [Related]
24. Complete sequencing of a cynomolgus macaque major histocompatibility complex haplotype.
Karl JA; Prall TM; Bussan HE; Varghese JM; Pal A; Wiseman RW; O'Connor DH
Genome Res; 2023 Mar; 33(3):448-462. PubMed ID: 36854669
[TBL] [Abstract][Full Text] [Related]
25. New Immunosuppressive Cell Therapy to Prolong Survival of Induced Pluripotent Stem Cell-Derived Allografts.
Sasaki H; Wada H; Baghdadi M; Tsuji H; Otsuka R; Morita K; Shinohara N; Seino K
Transplantation; 2015 Nov; 99(11):2301-10. PubMed ID: 26360665
[TBL] [Abstract][Full Text] [Related]
26. The Cynomolgus Macaque MHC Polymorphism in Experimental Medicine.
Shiina T; Blancher A
Cells; 2019 Aug; 8(9):. PubMed ID: 31455025
[TBL] [Abstract][Full Text] [Related]
27. Transplantation of T-cell receptor α/β-depleted allogeneic bone marrow in nonhuman primates.
D'Souza SS; Bennett S; Kumar A; Kelnhofer LE; Weinfurter J; Suknuntha K; Coonen J; Mejia A; Simmons H; Golos T; Hematti P; Capitini CM; Reynolds MR; Slukvin II
Exp Hematol; 2021 Jan; 93():44-51. PubMed ID: 33176119
[TBL] [Abstract][Full Text] [Related]
28. Generation of porcine induced pluripotent stem cells and evaluation of their major histocompatibility complex protein expression in vitro.
Park KM; Cha SH; Ahn C; Woo HM
Vet Res Commun; 2013 Dec; 37(4):293-301. PubMed ID: 23975685
[TBL] [Abstract][Full Text] [Related]
29. Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells.
Araki R; Uda M; Hoki Y; Sunayama M; Nakamura M; Ando S; Sugiura M; Ideno H; Shimada A; Nifuji A; Abe M
Nature; 2013 Feb; 494(7435):100-4. PubMed ID: 23302801
[TBL] [Abstract][Full Text] [Related]
30. Modulation of human allogeneic and syngeneic pluripotent stem cells and immunological implications for transplantation.
Sackett SD; Brown ME; Tremmel DM; Ellis T; Burlingham WJ; Odorico JS
Transplant Rev (Orlando); 2016 Apr; 30(2):61-70. PubMed ID: 26970668
[TBL] [Abstract][Full Text] [Related]
31. Generation of induced pluripotent stem cells (cmESF-iPS-C5) derived from cynomolgus monkey ear skin fibroblasts (cmESF).
Zhen X; Park SJ; Choe SH; Lee DS; Lee JH
Stem Cell Res; 2022 Dec; 65():102977. PubMed ID: 36403550
[TBL] [Abstract][Full Text] [Related]
32. Study on the Extrapolability of Current Tumorgenicity Test With Mice by Comparing the Syngeneic or Allogeneic Mouse Transplantation Model.
Tamura T; Tahara T; Inoue M; Nanjo R; Onoe H; Yamamoto T; Kawamata S
Stem Cells Transl Med; 2024 Jun; 13(6):572-581. PubMed ID: 38554123
[TBL] [Abstract][Full Text] [Related]
33. Allogeneic lymphocyte transfer in MHC-identical siblings and MHC-identical unrelated Mauritian cynomolgus macaques.
Mee ET; Stebbings R; Hall J; Giles E; Almond N; Rose NJ
PLoS One; 2014; 9(2):e88670. PubMed ID: 24523927
[TBL] [Abstract][Full Text] [Related]
34. Induced pluripotent stem cells have similar immunogenic and more potent immunomodulatory properties compared with bone marrow-derived stromal cells in vitro.
Schnabel LV; Abratte CM; Schimenti JC; Felippe MJ; Cassano JM; Southard TL; Cross JA; Fortier LA
Regen Med; 2014; 9(5):621-35. PubMed ID: 24773530
[TBL] [Abstract][Full Text] [Related]
35. Competency of iPSC-derived retinas in MHC-mismatched transplantation in non-human primates.
Uyama H; Tu HY; Sugita S; Yamasaki S; Kurimoto Y; Matsuyama T; Shiina T; Watanabe T; Takahashi M; Mandai M
Stem Cell Reports; 2022 Nov; 17(11):2392-2408. PubMed ID: 36306783
[TBL] [Abstract][Full Text] [Related]
36. Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients.
Deuse T; Hu X; Gravina A; Wang D; Tediashvili G; De C; Thayer WO; Wahl A; Garcia JV; Reichenspurner H; Davis MM; Lanier LL; Schrepfer S
Nat Biotechnol; 2019 Mar; 37(3):252-258. PubMed ID: 30778232
[TBL] [Abstract][Full Text] [Related]
37. MHC matching fails to prevent long-term rejection of iPSC-derived neurons in non-human primates.
Aron Badin R; Bugi A; Williams S; Vadori M; Michael M; Jan C; Nassi A; Lecourtois S; Blancher A; Cozzi E; Hantraye P; Perrier AL
Nat Commun; 2019 Sep; 10(1):4357. PubMed ID: 31554807
[TBL] [Abstract][Full Text] [Related]
38. Establishment of a complex skin structure via layered co-culture of keratinocytes and fibroblasts derived from induced pluripotent stem cells.
Kim Y; Park N; Rim YA; Nam Y; Jung H; Lee K; Ju JH
Stem Cell Res Ther; 2018 Aug; 9(1):217. PubMed ID: 30103800
[TBL] [Abstract][Full Text] [Related]
39. Induction of allograft tolerance by adoptive transfer of donor B cells: an immune regulatory strategy for transplantation using MHC-matched iPS cells.
Murata T; Otsuka R; Sasaki A; Kamatani T; Wada H; Yamakawa H; Hasegawa Y; Seino KI
Int Immunol; 2023 Jul; 35(7):327-338. PubMed ID: 37052267
[TBL] [Abstract][Full Text] [Related]
40. Direct
Xiang M; Lu M; Quan J; Xu M; Meng D; Cui A; Li N; Liu Y; Lu P; Kang X; Wang X; Sun N; Zhao M; Liang Q; Le L; Wang X; Zhang J; Chen S
Theranostics; 2019; 9(1):290-310. PubMed ID: 30662568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
